Comprehensive Cancer Centers
Comprehensive Cancer Centers of Nevada is a private multi-specialty oncology practice founded in 1974, operating 11+ treatment centers across Southern Nevada with 600+ medical professionals delivering medical, radiation, and surgical oncology, hematology, pulmonology, and clinical research services.
- Company typePrivate
- Founded1974
- HeadquartersHenderson, United States
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What Comprehensive Cancer Centers does
Comprehensive Cancer Centers of Nevada (CCC) is a private, for-profit multi-specialty medical oncology practice founded in 1974 and headquartered in Henderson, Nevada. The company delivers integrated cancer care across medical oncology, hematology, radiation oncology, breast surgery, and pulmonology, serving patients across Southern Nevada through 11+ treatment centers in Las Vegas, Henderson, and Boulder City. It employs more than 600 medical professionals and maintains a roster of 40+ physicians and 20+ advanced practice providers covering oncology subspecialties, breast surgery, pulmonology, genetic counseling, and advanced practice nursing.
CCC's core technology stack includes board-certified specialty clinical services, CyberKnife robotic radiosurgery, ION robotic bronchoscopy with 3D lung mapping, genetic counseling, diagnostic imaging, on-site laboratory services, medically integrated dispensing (on-site oncology pharmacy), and infusion therapy. The practice operates a clinical research program offering more than 170 Phase I, II, and III trials annually, with stated contribution to more than 100 FDA-approved cancer therapies. It is an affiliate of The US Oncology Network and recently established a collaboration with Sarah Cannon Research Institute (SCRI) that provides access to Genospace, a personalized medicine trial-matching tool.
Revenue is generated primarily through fee-for-service patient care billed to insurance plans and patients, supplemented by professional services revenue from clinical trial participation. GTM is sales-led via physician referrals, self-referrals, and online scheduling; distribution runs through treatment center locations, an online referral and appointment platform, and the Ontada Health patient portal. The practice serves individual cancer, hematology, pulmonology, and high-risk genetic counseling patients, with no enterprise customer concentration. Awards include multiple Castle Connolly and US News & World Report Top Doctor recognitions and regional workplace and healthcare leadership awards.
Comprehensive Cancer Centers firmographics
Firmographics- Name
- Comprehensive Cancer Centers
- Legal name
- Comprehensive Cancer Centers of Nevada
- Website
- https://cccnevada.com
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Comprehensive Cancer Centers of Nevada is a private multi-specialty oncology practice founded in 1974, operating 11+ treatment centers across Southern Nevada with 600+ medical professionals delivering medical, radiation, and surgical oncology, hematology, pulmonology, and clinical research services.
- Ownership category
- akta.pro rank
Comprehensive Cancer Centers industry classification
Industry- Product category
- Oncology / Cancer Care Services
- NAICS
- Offices of Physicians (62111), Ambulatory Health Care Services (621), Other Outpatient Care Centers (62149)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Surgical Oncology (HLAKAFAG), Thoracic (Lung) Oncology (HLAKAFAL), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)
Keywords
Where Comprehensive Cancer Centers is headquartered
LocationHeadquarters
- HQ city
- Henderson
- HQ country
- United States
- HQ region
- North America
Offices11 records
Markets served
Comprehensive Cancer Centers business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Patient Care Services: Direct medical services including oncology treatments, diagnostic imaging, laboratory services, and infusion therapies billed through insurance plans and patient payments.
- Clinical Research: Participation in clinical trials offering access to cutting-edge therapies, supported through affiliations with US Oncology Network and Sarah Cannon Research Institute.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Comprehensive Cancer Centers product offering
Product offeringCore offering
Comprehensive Cancer Centers is a multi-specialty medical oncology practice in Southern Nevada delivering integrated cancer and related care including medical oncology, hematology, radiation oncology, breast surgery, and pulmonology. It also provides chemotherapy, immunotherapy, CyberKnife radiosurgery, diagnostic imaging, laboratory services, genetic counseling, infusion therapy, and clinical research access.
Product overview
Comprehensive Cancer Centers is an award-winning multi-specialty medical oncology practice (affiliate of The US Oncology Network) offering integrated cancer care services across Southern Nevada. The practice provides a unified care model combining medical oncology, hematology, radiation oncology, breast surgery, pulmonology, genetic counseling, infusion services, and clinical research. Core treatment services include chemotherapy, immunotherapy, CyberKnife radiosurgery, diagnostic imaging, laboratory services, and medically integrated pharmacy dispensing. The practice also offers specialized lung cancer screening with low-dose CT and advanced bronchoscopy procedures. Through its SCRI at Comprehensive Cancer Centers collaboration with Sarah Cannon Research Institute, patients gain access to expanded clinical trials with Genospace-powered personalized medicine matching. Additional patient resources include the Ontada Health patient portal for secure access to care information.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Oncology Board-certified medical oncologists manage cancer treatment plans and therapies for patients in a supportive care environment.
- Hematology Cancer treatment options and therapies for serious blood disorders and blood cancers such as leukemia, lymphoma, and myeloma.
- Radiation Oncology Uses advanced treatment planning systems and state-of-the-art radiation technology to deliver internal and external radiation treatments.
- Breast Surgery Cancer-related and non-cancer surgeries and effective treatment options for breast care and breast cancer patients.
- Pulmonology Services Board-certified pulmonologists diagnose, treat, and educate adult patients with lung diseases and sleep disorders.
- Chemotherapy Standardized regimens using drugs that interfere with cancer cell growth and reproduction, often combined with radiation therapy and/or surgery.
- Immunotherapy Treatment using the body's own immune system to help fight cancer.
- CyberKnife Radiosurgery Painless, non-invasive tumor treatment requiring no anesthesia and shorter recovery times, using computer-operated robotics and image guidance technology.
- Infusion Services Infusion therapies delivered via IV for patients with chronic diseases including rheumatoid arthritis, lupus, multiple sclerosis, asthma, and cancer-related conditions.
- Lung Cancer Screening Low-dose CT screening for people at high risk for lung cancer, offered at ACR-designated Lung Cancer Screening Center radiation locations.
- Genetic Counseling Hereditary cancer risk assessment for patients who may be at risk of developing cancer, helping them make informed decisions about genetic testing based on family history.
- Diagnostic Imaging State-of-the-art imaging services providing convenient scan access for patients and timely results for physicians.
- Laboratory Services On-site laboratories providing quick lab test results to help physicians prescribe or adjust treatment plans without delays.
- Clinical Research More than 170 Phase I, II & III clinical trials annually, having helped develop over 100 FDA-approved cancer therapies.
- Radioisotope Therapy Specialized cancer treatment using radioactive isotopes to target and treat cancer cells.
- Medically Integrated Dispensing On-site pharmacy services where pharmacists trained in cancer treatment work with physicians and nurses to address complex therapies in outpatient settings.
- Bronchoscopy Services Diagnostic and staging procedures for lung cancer including Robotic Assisted Bronchoscopy (ION Endoluminal Platform) and Electromagnetic Navigation Bronchoscopy (Veran Platform).
- SCRI at Comprehensive Cancer Centers Collaboration with Sarah Cannon Research Institute expanding access to innovative cancer treatments and clinical trials across Southern Nevada, featuring Genospace personalized medicine trial matching.
- Ontada Health Patient Portal Secure, easy-to-navigate web portal giving patients access to information about their care and treatment plan.
Quantifiable outcome
- 100+ FDA-approved cancer therapies developed through clinical research
- +2 more outcomes
Companies that use Comprehensive Cancer Centers
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Comprehensive Cancer Centers technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Comprehensive Cancer Centers partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Sarah Cannon Research Institute (SCRI)coreCollaboration expanding Southern Nevada clinical trials through SCRI at Comprehensive Cancer Centers. Provides access to Genospace personalized medicine trial matching technology and advanced clinical trial matching using clinical and genetic data.
- The US Oncology NetworkcoreComprehensive Cancer Centers is an affiliate of The US Oncology Network, providing access to shared resources, clinical research infrastructure, and best practices in community oncology care.
- Optum-NevadaminorPartner organization showcasing mobile medical center at community health events including Aging Wellness Expo.
- Intermountain HealthminorSupporting sponsor for Aging Wellness Expo community health event.
- Select HealthminorSupporting sponsor for Aging Wellness Expo community health event.
- CenterWellminorSupporting sponsor for Aging Wellness Expo community health event.
- UMC (University Medical Center)minorSupporting sponsor for Aging Wellness Expo community health event.
Scale indicators7 records
Recent moves8 records
Expansion highlights5 records
Comprehensive Cancer Centers competitors and assessment
Company assessmentBroad incumbents
- City of Hope: NCI-designated specialty cancer hospital and research center; broader portfolio (inpatient + outpatient) but overlapping oncology service lines and clinical research mission.
- MD Anderson Cancer Center: Leading academic specialty cancer hospital; competes for high-acuity oncology cases and clinical-trial referrals even though operating model is academic rather than community-based.
Regional players
- Dignity Health (CommonSpirit): Hospital system operating St. Rose Dominican campuses in Henderson where Comprehensive Cancer Centers physicians hold chief-of-staff roles; competing and partner oncology footprint in Southern Nevada.
- Intermountain Health: Large regional health system with significant Nevada presence; competing provider of hospital-based oncology services and potential referral competitor for community oncology.
- Huntsman Cancer Institute: NCI-designated cancer center at University of Utah; comparable in combining research with multi-specialty oncology care but serving a different regional market.
Others
- Sarah Cannon Research Institute: Strategic research collaboration partner; comparable in clinical-trial throughput and oncology drug-development role rather than direct patient-care competition.
Direct peers
- Texas Oncology: Largest US Oncology Network affiliate with deep community oncology footprint, in-house research, and multi-specialty care; the most direct scale comparable for Comprehensive Cancer Centers.
- The US Oncology Network: Network of community oncology practices to which Comprehensive Cancer Centers is an affiliate; comparable multi-specialty community oncology model with shared research, payer contracting, and IT infrastructure.
- Florida Cancer Specialists & Research Institute: Large multi-site community oncology practice offering medical oncology, radiation oncology, and clinical trials; comparable in scale, multi-specialty integration, and US Oncology Network affiliation.
Emerging players
- UC San Diego Moores Cancer Center: NCI-designated academic cancer center; overlapping clinical research and specialty oncology services; one of Comprehensive Cancer Centers' board physicians previously held an oncology role there.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Comprehensive Cancer Centers social profiles
Digital presenceComprehensive Cancer Centers compliance and trust
Trust signalCompliance2 records
Comprehensive Cancer Centers financial estimates
Financial estimateRevenue estimate
Valuation estimate
Comprehensive Cancer Centers leadership team
Management profileNumber of profiles
Profiles13 records
Comprehensive Cancer Centers subsidiaries and ownership
Company hierarchySubsidiaries1 record
Comprehensive Cancer Centers funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Comprehensive Cancer Centers M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Comprehensive Cancer Centers
What does Comprehensive Cancer Centers do?
Comprehensive Cancer Centers is a multi-specialty medical oncology practice in Southern Nevada delivering integrated cancer and related care including medical oncology, hematology, radiation oncology, breast surgery, and pulmonology. It also provides chemotherapy, immunotherapy, CyberKnife radiosurgery, diagnostic imaging, laboratory services, genetic counseling, infusion therapy, and clinical research access.
Is Comprehensive Cancer Centers a public or private company?
Comprehensive Cancer Centers is a private company. It is classified as management employee owned and is currently operating.
When was Comprehensive Cancer Centers founded?
Comprehensive Cancer Centers was founded in 1974. It employs 501 to 1,000 people.
Where is Comprehensive Cancer Centers based?
Comprehensive Cancer Centers is headquartered in Henderson, United States, in the North America region.
How does Comprehensive Cancer Centers make money?
Two revenue lines are on record. Patient Care Services are the primary driver. The others are clinical Research.
Who are Comprehensive Cancer Centers's main competitors?
Broad incumbents on record are City of Hope and MD Anderson Cancer Center. Regional players are Dignity Health (CommonSpirit), Intermountain Health and Huntsman Cancer Institute. Sarah Cannon Research Institute is listed as an others. Direct peers are Texas Oncology, The US Oncology Network and Florida Cancer Specialists & Research Institute. UC San Diego Moores Cancer Center is listed as an emerging player.
Does Comprehensive Cancer Centers have an API?
No public API is recorded for Comprehensive Cancer Centers.
What industry is Comprehensive Cancer Centers in?
Comprehensive Cancer Centers's product category is Oncology / Cancer Care Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 62111 and its SIC code is 8011.